GlaxoSmithKline Pharma, celebrating 100 years in India, is shifting to a specialty-focused model by entering the oncology ...

Chartered Accountant, Statutory Auditors. Hexa Tradex Board Meeting Intimation for NOTICE PURSUANT TO REGULATION 29 OF SEBI (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) ... HEXA TRADEX LTD.has ...

CSL Seqirus, Sanofi and GSK have collectively secured $72 million in funding from the U.S. health department to boost the country’s supply of bird flu vaccines. The grant comes from the ...

As part of the agreement, GSK, Sanofi, and CSL will produce extra bulk vaccine components tailored to the circulating strains of avian influenza. Also Read: Medicare Drug Price Negotiation Program ...

J.P. Morgan analyst James Gordon maintained a Sell rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £15.50. The company’s shares closed yesterday at p1,497. ...

Goldman Sachs analyst Rajan Sharma maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £18.00. The company’s shares closed yesterday at p1,497. ...

GSK’s Vi­iV Health­care has sus­pend­ed de­vel­op­ment of a Phase 2-stage HIV an­tivi­ral named VH3739937, a GSK spokesper­son con­firmed to End­points News on Tues­day.

We recently made a list of the 10 Best Global Stocks To Buy Now. In this piece, we will look at where GSK plc (NYSE:GSK) ranks among the top ten global stocks to buy. With the third quarter of ...

In the coming years, epidemiological data on the safety of recently introduced vaccines will become available, especially for the H1N1 vaccine (the first analyses from the pregnancy registries ...

Vaccines used were the monovalent vaccines Engerix B and GenHBvax (Merck, West Point, PA), the hexavalent preparations Infanrix hexa (GlaxoSmithKline Biologicals) and Hexavac (Sanofi Pasteur ...

The world’s first RSV vaccines were approved by the FDA last year in the forms of GSK’s Arexvy and Pfizer’s Abrysvo. Both are designed to help prevent this common cold virus that can in the ...

GSK Plc CEO Emma Walmsley doesn’t want the company’s employees spending any time thinking about the ongoing litigation over its old heartburn drug Zantac, an issue that has weighed on the ...